Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
7,77 USD | +1,97% | +2,64% | -7,94% |
02/04 | Voyager Therapeutics, Inc. nomina Robin Swartz come Principale Contabile | CI |
26/03 | VOYAGER THERAPEUTICS, INC. : Guggenheim ribadisce il giudizio positivo sul titolo | ZM |
Attività
Numero di dipendenti: 162
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Therapies
100,0
%
| 41 | 100,0 % | 250 | 100,0 % | +511,16% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 41 | 100,0 % | 250 | 100,0 % | +511,16% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01/03/22 |
Michael Higgins
CHM | Chairman | 61 | 22/07/15 |
Director of Finance/CFO | 55 | 19/09/22 | |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/11/18 |
Robin Swartz
COO | Chief Operating Officer | 53 | 01/09/21 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 05/01/17 |
James Geraghty
BRD | Director/Board Member | 70 | 01/01/14 |
Beth Shafer
PRN | Corporate Officer/Principal | - | 07/08/23 |
Human Resources Officer | - | 14/09/20 | |
General Counsel | - | 10/07/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 09/05/23 |
James Geraghty
BRD | Director/Board Member | 70 | 01/01/14 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 05/01/17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 15/08/22 |
Steven E. Hyman
BRD | Director/Board Member | 71 | 17/09/15 |
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01/03/22 |
Grace E. Colón
BRD | Director/Board Member | 57 | 01/01/23 |
Nancy J. Vitale
BRD | Director/Board Member | - | 15/09/20 |
Michael Higgins
CHM | Chairman | 61 | 22/07/15 |
Jude Onyia
BRD | Director/Board Member | 60 | 21/02/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 54 388 336 | 45 192 190 ( 83,09 %) | 0 | 83,09 % |
Coordinate società
Voyager Therapeutics, Inc.
75 Hayden Avenue
02421, Lexington
+857 259 5340
http://www.voyagertherapeutics.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-7,94% | 423 Mln | |
+1,77% | 42,86 Mrd | |
+45,38% | 41,36 Mrd | |
+12,24% | 42,74 Mrd | |
-8,83% | 27,68 Mrd | |
+7,44% | 25,15 Mrd | |
-23,01% | 18,63 Mrd | |
+30,56% | 12,37 Mrd | |
-1,82% | 11,92 Mrd | |
+8,35% | 11,21 Mrd |
- Borsa valori
- Azioni
- Azione VYGR
- Società Voyager Therapeutics, Inc.